Search - tctmd.com

Displaying 1 - 20 of 69

Sort: Relevancy | Date

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Daily News

Biomarkers Added to a Polygenic Risk Score Equals Better CAD Prediction

Yael L. Maxwell

October 23, 2025

News Daily News

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

Caitlin E. Cox

October 16, 2025

News Daily News

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Michael O'Riordan

July 14, 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2023

Shelley Wood

November 30, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2023

Caitlin E. Cox

September 04, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Conference News ADA 2023

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Michael O'Riordan

June 28, 2023

News Daily News

FDA Approves Colchicine for Decreasing CV Events

Caitlin E. Cox

June 20, 2023

News Conference News ACC 2023

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Caitlin E. Cox

March 14, 2023

News Conference News ACC 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Michael O'Riordan

March 04, 2023

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

Advertisement

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Biomarkers Added to a Polygenic Risk Score Equals Better CAD Prediction

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Will Semaglutide Change Cardiac Surgery? It Already Has

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

TCTMD’s Top 10 Most Popular Stories for November 2023

TCTMD’s Top 10 Most Popular Stories for August 2023

September 2023 News Roundup

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

FDA Approves Colchicine for Decreasing CV Events

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content